Olean Times Herald

MALVERN, Pa. , April 7, 2025 /PRNewswire/ --Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report first quarter 2025 ...

- Endo is the first pharmaceutical company to launch an external spatial computing program. - The Spatial Computing Injection Simulator allows hand sp...

MALVERN, Pa. , March 24, 2025 /PRNewswire/ --Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX ® (collagenase clostridi...

MALVERN, Pa. , March 13, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today reported financial results for the fourth quart...

MALVERN, Pa. , March 12, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XI...

MALVERN, Pa. , March 11, 2025 /PRNewswire/ -- Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agre...

MALVERN, Pa. , March 10, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it has rescheduled the release o...

MALVERN, Pa. , Feb. 27, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today a presentation related to Peyronie's disease will be shared duri...

MALVERN, Pa. , Feb. 21, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report fourth quarter and...